search
Back to results

Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only

Primary Purpose

Congenital Nasolacrimal Duct Obstruction

Status
Unknown status
Phase
Phase 2
Locations
Egypt
Study Type
Interventional
Intervention
Endodiathermy Probe and Intubation Versus Intubation
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Congenital Nasolacrimal Duct Obstruction focused on measuring Endodiathermy Probe and Intubation Versus Intubation Only

Eligibility Criteria

2 Years - 7 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Children in the age group above 2 years old
  2. No history of previous probing.
  3. No history of previous intubation.
  4. Children with no any other association or congenital anomalies cause watery eye.
  5. children suffer from congenital nasolacrimal duct obstruction.

Exclusion Criteria:

  1. children less than 2 years old.
  2. previous probing.
  3. previous intubation.
  4. children with any other congenital anomalies as congenital ectropion , congenital entropion
  5. children suffer from any upper lacrimal anomalies as obstruction or stenosis.

Sites / Locations

  • Abo El Resh Pedriatric Hospital Cairo UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

classic intubation

endodiathermy probe

Arm Description

children suffer from congenital nasolacrimal duct obstruction will have probing with metal probe and then intubation with bicanlicular silicon tube.

children suffer from congenital nasolacrimal duct obstruction will have probing with endodiathermy probe and then intubation with bicanlicular silicon tube

Outcomes

Primary Outcome Measures

recanalization of nasolacrimal duct
compare the efficiency of endodiathermy probe followed by intubation versus probing with metal probe followed by intubation by epiphora (overflow of tears onto the face) increase tear film meniscus ( more than 1mm in height) mucous discharge Fluorescein disappearance test (Normally, little or no dye remains after 5 minutes. Prolonged retention is indicative of inadequate lacrimal drainage)

Secondary Outcome Measures

complication
Record any complication in two procedures as tube migration, tube extrusion, infection or need for additional procedure.

Full Information

First Posted
October 27, 2019
Last Updated
October 30, 2019
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT04148170
Brief Title
Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only
Official Title
Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 2020 (Anticipated)
Primary Completion Date
June 2020 (Anticipated)
Study Completion Date
September 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the current work is to assess the efficiency and success rate of endodiathermy probe followed by intubation in children more than 2 years compared to the success rate of intubation (as a standard method) which varies from 75% to 85% in several studies
Detailed Description
The study will be conducted on children above 2 year and will be divided randomly into two groups: Group (I): 80 eyes of children suffer from congenital nasolacrimal duct obstruction will have probing with metal probe and then intubation with bicanlicular silicon tube. Group (II): 80 eyes of children suffer from congenital nasolacrimal duct obstruction will have probing with endodiathermy probe and then intubation with bicanlicular silicon tube

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Nasolacrimal Duct Obstruction
Keywords
Endodiathermy Probe and Intubation Versus Intubation Only

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Group (I): 80 eyes of children suffer from congenital nasolacrimal duct obstruction will have probing with metal probe and then intubation with bicanlicular silicon tube. Group (II): 80 eyes of children suffer from congenital nasolacrimal duct obstruction will have probing with endodiathermy probe and then intubation with bicanlicular silicon tube.
Masking
Participant
Masking Description
all will be know the surgical procedure but participant will know only that he will be treated but cant understand type of procedure done
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
classic intubation
Arm Type
Active Comparator
Arm Description
children suffer from congenital nasolacrimal duct obstruction will have probing with metal probe and then intubation with bicanlicular silicon tube.
Arm Title
endodiathermy probe
Arm Type
Active Comparator
Arm Description
children suffer from congenital nasolacrimal duct obstruction will have probing with endodiathermy probe and then intubation with bicanlicular silicon tube
Intervention Type
Procedure
Intervention Name(s)
Endodiathermy Probe and Intubation Versus Intubation
Intervention Description
children suffer from congenital nasolacrimal duct obstruction will have probing with endodiathermy probe and then intubation with bicanlicular silicon tube
Primary Outcome Measure Information:
Title
recanalization of nasolacrimal duct
Description
compare the efficiency of endodiathermy probe followed by intubation versus probing with metal probe followed by intubation by epiphora (overflow of tears onto the face) increase tear film meniscus ( more than 1mm in height) mucous discharge Fluorescein disappearance test (Normally, little or no dye remains after 5 minutes. Prolonged retention is indicative of inadequate lacrimal drainage)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
complication
Description
Record any complication in two procedures as tube migration, tube extrusion, infection or need for additional procedure.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Children in the age group above 2 years old No history of previous probing. No history of previous intubation. Children with no any other association or congenital anomalies cause watery eye. children suffer from congenital nasolacrimal duct obstruction. Exclusion Criteria: children less than 2 years old. previous probing. previous intubation. children with any other congenital anomalies as congenital ectropion , congenital entropion children suffer from any upper lacrimal anomalies as obstruction or stenosis.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
mohamed hafez ibrahim
Phone
00201224010523
Email
monsieur84@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
karim elessawy
Phone
00201144008882
Email
kemos1984@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
tamer gawdat, professor
Organizational Affiliation
professor of ophthalmology cairo university
Official's Role
Principal Investigator
Facility Information:
Facility Name
Abo El Resh Pedriatric Hospital Cairo University
City
Cairo
ZIP/Postal Code
31111
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
karim bakr, lecture
Phone
00201144008882
Email
kemos1984@yahoo.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
after finishiny my research can share my data
IPD Sharing Time Frame
1 year untill 1 year and 6 months
IPD Sharing Access Criteria
after finish my study
Citations:
PubMed Identifier
25370408
Citation
Suranagi PV, Poornima MS; Smruthi; Banagar B. Regarding a novel technique to recanalize the nasolacrimal duct with endodiathermy bipolar probe. Indian J Ophthalmol. 2014 Sep;62(9):971. doi: 10.4103/0301-4738.143956. No abstract available.
Results Reference
result

Learn more about this trial

Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only

We'll reach out to this number within 24 hrs